drug

M-102

Preclinicalupdated 3mo ago

by Aclipse Therapeutics LLC

Preclinical

community read0 votes

indications

ALS

all catalysts(0)

nothing on the calendar yet

Trials studying M-102

phase1A Phase 1 Study of IM-1021 in Participants With Advanced Cancerrecruitingn=117
phase2A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDDcompletedn=46

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

M-102

Preclinicalupdated 3mo ago

by Aclipse Therapeutics LLC

Preclinical

community read0 votes

indications

ALS

all catalysts(0)

nothing on the calendar yet

Trials studying M-102

phase1A Phase 1 Study of IM-1021 in Participants With Advanced Cancerrecruitingn=117
phase2A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDDcompletedn=46

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 40m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

M-102

indications

all catalysts(0)

Trials studying M-102

News(0)

Report a data issue

comments(0)

M-102

indications

all catalysts(0)

Trials studying M-102

News(0)

Report a data issue

comments(0)